Home » Topics » BioWorld Science

BioWorld Science
RSS

MM-3122, a novel TMPRSS2 inhibitor with antiviral activity against SARS-CoV-2 and MERS-CoV

Nov. 5, 2021

Parkinson's disease model confirms metabolic, contests anatomic tenets

Nov. 5, 2021

Japanese researchers disclose new SPR inhibitors

Nov. 5, 2021

Teijin Pharma and Amgen synthesize TRPC6 antagonists

Nov. 5, 2021

BPN-15477 corrects splicing defect caused by the c.2988G>A variant in CFTR

Nov. 5, 2021

Qilu Pharmaceutical presents EGFR inhibitors for lung cancer

Nov. 5, 2021

Beijing Scitech-Mq Pharmaceuticals divulges EGFR and/or HER2 inhibitors

Nov. 5, 2021

Chengdu Baiyu Pharmaceutical patents DNA-PK inhibitors

Nov. 5, 2021

ELD-607 reduces pulmonary inflammation and lung damage in vivo

Nov. 5, 2021

SP-101 administration restores airway epithelial function in cystic fibrosis

Nov. 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...